This study was aimed at the evaluation of the anti-inflammatory activity of twelve compounds isolated from the methanolic extract of fruits of Terminalia chebula. The activity was determined in terms of their ability to inhibit inducible nitric oxide synthase (iNOS) and cyclooxygenase-2 (COX-2) in LPS-stimulated macrophages. Two gallotannins [chebulinic acid (1) and 2,3,6-tri-O-galloyl-β-D-glucose (2)] and two triterpenoids [arjunic acid (3) and arjunolic acid (4)] efficiently reduced nitric oxide (NO) production with IC50 values of 53.4, 55.2, 48.8, and 38.0 μM, respectively. The protein expressions of iNOS and COX-2 were decreased in macrophages by treatment with compounds 1–4 (54–69% and 33–37%, respectively) at 50 μM. This is the first report of anti-inflammatory property of 1–4 mediated by inhibition of iNOS and COX-2 activities at the cellular level.
MichelT., FeronO. (1997) Nitric oxide synthases: which, where, how, and why?The Journal of Clinical Investigation, 100, 2146–2152.
2.
GuzikT.J., KorbutR., Adamek-GuzikT. (2003) Nitric oxide and superoxide in inflammation and immune regulation. Journal of Physiology and Pharmacology, 54, 469–487.
3.
SimonL.S. (1999) Role and regulation of cyclooxygenase-2 during inflammation. The American Journal of Medicine, 106, 37S–42S.
4.
ColemanJ.W. (2001) Nitric oxide in immunity and inflammation. International Immunopharmacology, 1, 1397–1406.
5.
PellatiF., BruniR., RighiD., GrandiniA., TognoliniM., Pio PrencipeF., PoliF., BenvenutiS., Del RioD., RossiD. (2013) Metabolite profiling of polyphenols in a Terminalia chebula Retzius ayurvedic decoction and evaluation of its chemopreventive activity. Journal of Ethnopharmacology, 147, 277–285.
6.
PfundsteinB., El DesoukyS.K., HullW.E., HaubnerR., ErbenG., OwenR.W. (2010) Polyphenolic compounds in the fruits of Egyptian medicinal plants (Terminalia bellerica, Terminalia chebula and Terminalia horrida): Characterization, quantitation and determination of antioxidant capacities. Phytochemistry, 71, 1132–1148.
7.
YangM.H., VasquezY., AliZ., KhanI.A., KhanS.I. (2013) Constituents from Terminalia species increase PPARα and PPARγ levels and stimulate glucose uptake without enhancing adipocyte differentiation. Journal of Ethnopharmacology, 149, 490–498.
8.
JagetiaG.C., RaoS.K., BaligaM.S., BabuK. (2004) The evaluation of nitric oxide scavenging activity of certain herbal formulations in vitro: a preliminary study. Phytotherapy Research, 18, 561–565.
9.
ReddyD.B., ReddannaP. (2009) Chebulagic acid (CA) attenuates LPS-induced inflammation by suppressing NF-kappaB and MAPK activation in RAW 264.7 macrophages. Biochemical and Biophysical Research Communications, 381, 112–117.
10.
NairV., SinghS., GuptaY.K. (2010) Anti-arthritic and disease modifying activity of Terminalia chebula Retz. in experimental models. Journal of Pharmacy and Pharmacology, 62, 1801–1806.
11.
EldeenI.M., Van HeerdenF.R., Van StadenJ. (2008) Isolation and biological activities of termilignan B and arjunic acid from Terminalia sericea roots. Planta Medica, 74, 411–413.
YokozawaT., ChenC.P., DongE., TanakaT., NonakaG.I., NishiokaI. (1998) Study on the inhibitory effect of tannins and flavonoids against the 1,1-diphenyl-2 picrylhydrazyl radical. Biochemical Pharmacology, 56, 213–222.
14.
SunF.Y., ChenX.P., WangJ.H., QinH.L., YangS.R., DuG.H. (2008) Arjunic acid, a strong free radical scavenger from Terminalia arjuna. The American Journal of Chinese Medicine, 36, 197–207.
15.
GhoshJ., DasJ., MannaP., SilP.C. (2010) Arjunolic acid, a triterpenoid saponin, prevents acetaminophen (APAP)-induced liver and hepatocyte injury via the inhibition of APAP bioactivation and JNK-mediated mitochondrial protection. Free Radical Biology & Medicine, 48, 535–553.
16.
MaxwellS.R. (1995) Prospects for the use of antioxidant therapies. Drugs, 49, 345–361.
17.
WangS., MelnykJ.P., TsaoR., MarconeM.F. (2011) How natural dietary antioxidants in fruits, vegetables and legumes promote vascular health. Food Research International, 44, 14–22.
18.
WahliW., MichalikL. (2012) PPARs at the crossroads of lipid signaling and inflammation. Trends in Endocrinology & Metabolism, 23, 351–363.
19.
DonathM.Y., ShoelsonS.E. (2011) Type 2 diabetes as an inflammatory disease. Nature Reviews Immunology, 11, 98–107.
20.
CostaG., FranciscoV., LopesM.C., CruzM.T., BatistaM.T. (2012) Intracellular signaling pathways modulated by phenolic compounds: application for new anti-inflammatory drugs discovery. Current Medicinal Chemistry, 19, 2876–2900.
